Reversible drug-induced sterility in a patient with acute leukemia.
D000284:Administration, Oral; D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D005500:Follow-Up Studies; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D010334:Paternity; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013094:Spermatozoa / Q000032:analysis; D013997:Time Factors
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate